MIT finds coverage gaps in COVID-19 drugs

Tiernan Ray tells Karen Roby a study by MIT scholars used novel machine learning programs to detect that people of Black or Asian genetic ancestry may not be as well covered by so-called Warp Speed COVID-19 drugs from Moderna, Pfizer, and AstraZeneca. Read more: http://zd.net/2K7G3Z5